Tomi Jun - Concepedia

Author

Tomi Jun

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Jun, Tomi, T Jun, T. Jun, Takaki Jun, Team Leader: Ellie Jun, Team Member: Ellie Jun, Thomas Gyuchan Jun, Tomi Jun, Tomi W. Jun, Tomi Wei Jun

142

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Humanitas University Presbyterian Hospital University Medical Center Freiburg University of Freiburg

About

Tomi Jun is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	219
2	Epidemiology	3	3	60
3	Health Sciences	2	2	121
4	Public Health	2	2	44
5	Emergency Medicine	1	1	16

Tomi Jun

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19 Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld, Thrombosis Research	2020	129
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial Matthew D. Galsky, Siamak Daneshmand, Sudeh Izadmehr, Nature Medicine	2023	113
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial Jayesh Desai, Guzmán Alonso, Se Hyun Kim, Nature Medicine	2023	106
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, Cancers	2021	78
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade David J. Pinato, Takahiro Kaneko, Anwaar Saeed, Cancers	2020	74
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice David J. Pinato, Thomas U. Marron, Pallavi S. Mishra‐Kalyani, European Journal of Cancer HepatologyLandmark Clinical TrialsMedicineImmunologyClinical Trials	2021	62
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study Petros Fessas, Ahmed O. Kaseb, Yinghong Wang, Journal for ImmunoTherapy of Cancer PathologyPost-registration ExperienceOncologyInternational StudyBackground Nivolumab	2020	59
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma Petros Fessas, Muntaha Naeem, Matthias Pinter, Liver Cancer	2021	59
Genomic and molecular features distinguish young adult cancer from later-onset cancer William Lee, Zishan Wang, Miriam Saffern, Cell Reports	2021	50
Analysis of sex-specific risk factors and clinical outcomes in COVID-19 Tomi Jun, Sharon Nirenberg, Tziopora Weinberger, Communications Medicine	2021	46

Page 1